
Bangkok Hospital Delegation Visits Jiahui Health for In-Depth Oncology Exchanges
June 01, 2026
A delegation from Bangkok Hospital visited Jiahui Health for exchanges on oncology diagnosis, treatment and innovation — from surgery to CAR-T and new anti-tumor drugs in China.
Recently, a delegation from Bangkok Hospital visited Jiahui Health, and the two sides held exchanges focusing on oncology diagnosis, treatment, and innovation.
The visiting delegation included Dr. Thianchai Bunnalai, Vice President of Wattanosoth Cancer Hospital, and his team. Dr. Xiang Naiqiang, Chairman of the Management Executive Committee of Jiahui Health; Dr. Xuan Linli, Director of Medical Oncology at Jiahui International Cancer Center; Dr. Li Jun, Director of Surgery; Dr. Zhang Lihua, Head of the Radiotherapy Department at Jiahui International Cancer Center; and others warmly participated in the reception and exchanges.
After gaining an in-depth understanding of Jiahui's comprehensive medical service model, the two sides focused on cutting-edge topics in clinical oncology — ranging from surgical operations to advanced and sophisticated therapies such as CAR-T, as well as the application of new anti-tumor drugs in China. Bangkok Cancer Hospital also shared its professional expertise and rich clinical experience in oncology diagnosis and treatment.
During the exchanges, the two international medical institutions discussed the possibility of collaboration, and will jointly commit to promoting medical progress, deepening cross-border cooperation, and facilitating mutual development in the future. It is such partnerships that strengthen the conviction that working hand in hand is the key path to shaping the future of oncology diagnosis and treatment.




